Mobile medical services life support kits

Three features to extend service intervals: Cool running slows rate of corrosion and slows down rates of oil consumption Large oil capacity minimizes the rates of oil breakdown and reduces chemical attack within pump Internal surface protection on

Z-YVAD-FMK.

Z-YVAD-FMK.

InformationZ-YVAD-FMK is a cell-permeable and irreversiblecaspase-1specific inhibitor with anti-inflammatory and anti-tumor activities.Targetscaspase-1In vitroZ-YVAD-FMK treatment significantly reduces the increased caspase-1 activity induced by

InformationZ-YVAD-FMK is a cell-permeable and irreversiblecaspase-1specific inhibitor with anti-inflammatory and anti-tumor activities.Targetscaspase-1In vitroZ-YVAD-FMK treatment significantly reduces the increased caspase-1 activity induced by

InformationZ-YVAD-FMK is a cell-permeable and irreversiblecaspase-1specific inhibitor with anti-inflammatory and anti-tumor activities.Targetscaspase-1In vitroZ-YVAD-FMK treatment significantly reduces the increased caspase-1 activity induced by

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.

InformationRSV604 RSV604 (A-60444), a novel benzodiazepine, is an inhibitor of respiratory syncytial virus (RSV) with EC50 of 0.86 μM. RSV604 has significant potential for the effective treatment of RSV disease. Phase 2.TargetsRSV (Cell-free assay)

InformationRSV604 RSV604 (A-60444), a novel benzodiazepine, is an inhibitor of respiratory syncytial virus (RSV) with EC50 of 0.86 μM. RSV604 has significant potential for the effective treatment of RSV disease. Phase 2.TargetsRSV (Cell-free assay)

InformationRSV604 RSV604 (A-60444), a novel benzodiazepine, is an inhibitor of respiratory syncytial virus (RSV) with EC50 of 0.86 μM. RSV604 has significant potential for the effective treatment of RSV disease. Phase 2.TargetsRSV (Cell-free assay)

InformationRSV604 RSV604 (A-60444), a novel benzodiazepine, is an inhibitor of respiratory syncytial virus (RSV) with EC50 of 0.86 μM. RSV604 has significant potential for the effective treatment of RSV disease. Phase 2.TargetsRSV (Cell-free assay)